Filing Details

Accession Number:
0001104659-22-129516
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-22 16:06:22
Reporting Period:
2022-12-21
Accepted Time:
2022-12-22 16:06:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1425205 Iovance Biotherapeutics Inc. IOVA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1210317 A Merrill Mcpeak C/O Iovance Biotherapeutics, Inc.
825 Industrial Road, 4Th Floor
San Carlos CA 94070
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-21 10,000 $6.15 70,150 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 238,633 Indirect By Trust
Footnotes
  1. These shares are held by a family trust for which the reporting person is a trustee.